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ENDOTOXIN shockwas induced in 31 anaesthetized pigs by
infusion of 5 lig/kg of Escbeicbia coli endotoxin (LPS)
over 60 mtn into the superior mesenteric artery. Fifteen
of these pigs died wRhin 30 min of the start of LPS
infusion whereas the remaining 16 survived the experi-
mental period of 2 h. In a group of nine pigs indo-
methacin (2 mg/kg, i.v.)was inected 20-25 rain after the
start of LPS infusion at which time mean arterial blood
pressure (MABP) had decreased below 40 mmHg indicat-
ing imminent death. Indomethacin immediately reversed
the hypotension. In another group of five pigs, 2Ca-nitro
L-arginine-methyl ester (L-NAME, 1 and 3 mg/kg)was
iniected 10 and 5 min, respectively, before the expected
death without any beneficial effect on the hypotension.
Three rain after the last dose ofL-NAME, indomethacin (2
mg/kg, i.v.) was iniected. In three animals the hypoten-
sion was reservedby indomethacin, although this benefi-
cial effect was delayed in comparison with the LPS-
treated group not receiving L-NAME. Four pigs were
pretreated with L-NAME, 3 mg/kg, i.v., 10 min prior to LPS
tnfiton. All pretreated animals tended to die within 30
mtn of the start of the LPS infusion. Five rain before the
expected death (20-25 rain after the start ofLPS infusion)
tndomethacin (2 mg/kg) was inected. In three of these
animals indomethacin reversed hypotenston and pre-
vented death. Interestingly, this rise in the MABP deveb
opedvery slowly. These results suggest that the beneficial
effect of indomethacin in endotoxin shock might be re-
lated partially to interference with nitric oxide, which is
not the only factor determining blood pressure levels
during endotoxic shock.
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Introduction
It is becoming increasingly clear that septic shock
represents a generalized inflammatory reaction with
the induction of a number of mediators similar to
local inflammatory reactions. 1,’ Endotoxin and other
bacterial products also induce the production of
powerful mediators like eicosanoids, platelet-activat-
ing factor and cytokines. Recently, nitric oxide (NO)
has been suggested to be involved in the hypoten-
sion observed during endotoxin shock in dogs and
rats.4.
Non-steroid anti-inflammatory drugs (NSAIDs) rep-
resent a rational approach to break up the chain of
mediators because of their ability to inhibit the
cyclooxygenase enzyme, and this action may ac-
count for the clinical effectiveness of NSAIDs. We
have previously demonstrated that the administra-
tion of indomethacin during endotoxin shock pre-
vented death and improved the shock state. The
beneficial effect on blood pressure was rapid in
onset, reaching its maximum with 60 s, indicating a
direct vasoconstrictor effect.: Since blood pressure
was restored with 90 s of inhibition of NO synthesis
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during endotoxin shock in dogs, one can assume
some interrelationship between the effects of
indomethacin and NO. The aim of the present
investigation was to explore the existence of such a
relationship.
Materials and Methods
General: After an overnight fast, female Yorkshire x
Landrace pigs (body weight, 20-24 kg; age, 12-15
weeks) were initially anaesthetized with i.m. injec-
tions of ketamine (20 mg/kg) and midazolam (0.25
mg/kg) as well as atropine (0.005 mg/kg). The anaes-
thesia was maintained throughout the experiment
with i.v. sodium pentobarbitone (20 mg/kg bolus
followed by 20 mg/kg/h infusion). After intubation
the animals were ventilated with intermittent positive
pressure (Bear 2E adult volume ventilator, Lameris,
The Netherlands). Respiratory rate, tidal volume and
oxygen to air ratio were adjusted to provide arterial
blood gases within normal ranges at baseline: pH
7.35-7.45, pO2 90-150 mmHg and pCO 35-’45
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mmHg. Arterial blood gases and pH were measured
with a blood gas analyser (ABL-510, Radiometer,
Copenhagen, Denmark). Body temperature, meas-
ured with a thermometer (Philips, HP 5311, Japan)
attached to the liver, was maintained at around 38C
by using an electric blanket.
Catheters were placed via the femoral vessels into
the aorta and pulmonary artery (Swan-Ganz 7F cath-
eter). A midline laparotomy was performed and the
superior mesenteric artery was exposed. After gently
clearing the surrounding fat, nerves and connective
tissues, a needle (0.5 mm external diameter) con-
nected to a suitable polyethylene tube was inserted
directly into the superior mesenteric artery for infu-
sion of LPS or normal saline. The abdomen was then
closed and a Ringer-lactate infusion at a rate of 4 ml/
kg/h was started. The animals were allowed to re-
main undisturbed for at least 30 min to ensure
haemodynamic and respiratory stability. Mean arte-
rial blood pressure (MABP) and mean pulmonary
arterial pressure (MPAP) were continuously moni-
tored by electromanometers with Statham P23 dB
strain gauges (Hato Rey, Puerto Rico). Cardiac output
(CO) was determined intermittently by thermo-
dilution (WTI Computer, Rotterdam, Holland); each
measurement was performed in triplicate and their
readings averaged.
Experimental protocols:
Group I, Sham operated. Five animals were prepared
as described above except that instead of LPS (see
Group II), normal saline was infused into the supe-
rior mesenteric artery.
Group II, LPS induced shock. Thirty-one pigs were
infused with 5 lttg/kg Escherichia coli endotoxin
(LPS, Olll B4, Serva) into the superior mesenteric
artery over a 60-min period and the animals were
observed for an additional 60-min period.
Group III, indomethacin revived. In nine pigs, just
after the mean arterial blood pressure hal decreased
below 40 mmHg at 20-25 min after the start of the
LPS infusion, indomethacin (2 mg/kg i.v.) was in-
jected.
Group IV, L-NAMEpost-LPS treatment, indomethacin
revived. In five pigs, just after the mean arterial blood
pressure had decreased below 40 mmHg at 20-25
min after starting the LPS infusion, t-NAME (1 and 3
mg/kg) was given 10 and 5 min, respectively, before
the expected death. Three min after the last dose of
t-NAME, indomethacin (2 mg/kg, i.v.) was injected.
Group V, L-NAMEpre-LPS treatment, indo- methacin
received. Four animals were pretreated with t-NAME,
3 mg/kg, 10 min prior to LPS infusion. All animals
tended to die at or close to the critical 30 min after
the start of the LPS infusion. Five min before the
expected death indomethacin (2 mg/kg, i.v.) was
injected.
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Statistical analysis: All values are expressed as mean
_+ S.E.M. The data were evaluated by a non-paramet-
ric two-way analysis of variance (Friedman test) fol-
lowed by a Wilcoxon test to isolate differences be-
tween measurements performed during the control
period and at different times during and after LPS
infusion. The Mann-Whitney U test was performed
to evaluate the differences between the groups. A p
value of 0.05 or less was considered statistically
significant for all tests.
Results
Animal survival: A total of 49 pigs received a LPS
infusion for 60 min (Groups II, III, IV and V); Group
II consisted of 31 animals which were treated with
LPS only. In this group, 15 animals died at or close
to 30 min after the start of LPS infusion (non-survi-
vors). The remaining 16 animals survived the experi-
mental period of 2 h (i.e. 60 min after termination of
the LPS infusion) though in a state of shock (survi-
vors). None of the animals receiving indomethacin (2
mg/kg), 20-25 min after starting LPS infusion (Group
III), died during the observation period of 60 min. t-
NAME (1 and 3 mg/kg), administered 10 and 5 min
respectively, before the expected death, failed to
revive the animals. Four pigs pretreated with t-NAME
(3 mg/kg) tended to die at or close to 30 min after
starting LPS infusion. In six of nine animals receiving
t-NAME (pre- or post-LPS), indomethacin prevented
death at or close to 30 min after starting LPS infusion.
However, this beneficial effect was markedly delayed
compared with the group treated with LPS, but not
receiving r-NAME.
Systemic haemodynamics: As depicted in Fig. 1, no
changes in systemic haemodynamics were observed
in sham-operated animals. In non-surviving pigs, LPS
infusion decreased MABP to 29 _+ 2 mmHg whereas
MPAP was increased to 45 _+ 2 mmHg and CO fell to
0.93 -+ 0.1 1/min, shortly before death (30 min after
the start of LPS infusion). In surviving pigs treated
with LPS infusion, MABP gradually decreased to 71
_+ 4 mmHg at the end of 60 min observation period
(60 min after the end of LPS infusion); MPAP first
increased to peak values at 30 min before decreasing
slightly but remaining above baseline values; CO first
decreased rapidly 15-30 min after the start of the LPS
infusion and then gradually to about 59% of the
baseline value (Fig. 1A).
In animals revived with indomethacin (Group III),
MABP increased dramatically immediately after
indomethacin, to stabilize from 60 s onwards around
the baseline value. MPAP was reduced but remained
slightly elevated, whereas CO was transiently el-
evated and then decreased to a similar level as in
untreated LPS-infused survivors (Fig. 1B). A typicalIndomethacin, NO and endotoxin shock
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FIG. 1. The effect of saline or endotoxin (LPS, 5 Ig/kg/h) infusion on systemic haemodynamics in untreated pigs (Panel A) and in pigs treated with
indomethacin only (Panel B); in pigs treated with L-NAME + indomethacin during LPS infusion (Panel C) or in pigs treated with L-NAME before LPS
infusion and with indomethacin during LPS infusion (Panel D). Panel A. (A), sham-operated saline-treated animals (n 5); (O), non-surviving animals
(n 15) and (O), surviving animals (n 16). Panel B, (O), non-survivors (n 9) treated with indomethacin only. Panel C, (<>), non-survivors (n
5) treated with L-NAME and indomethacin. Panel D, (V), L-NAME pretreated animals (n 4). Arrows indicate the time of administration of either LPS,
L-NAME or indomethacin, as appropriate. Abbreviations: MABP, mean arterial blood pressure; CO, cardiac output; MPAP, mean pulmonary arterial
pressure. Values are given as means +/- S.E.M. *significantly different from baseline values (p < 0.05).
recording of the immediate reversal of MABP in-
duced by indomethacin in an animal treated with LPS
is shown in Fig. 2A.
In Group IV, five animals tended to die within 30
min after the start of LPS, and t-NAME (1 and 3 mg/
kg), given 10 and 5 min, respectively, before the
expected death, failed to prevent the drop in MABP
(to 20 _+ 2 mmHg) and the increase in MPAP (to 39
+ 4 mmHg) as well as the reduction in CO (to 1.0 _+
0.1 1/min). Three min after the last administration of
t-NAME, indomethacin (2 mg/kg) was injected. This
treatment was effective in restoring MABP in only
three of five animals. Furthermore, in contrast to the
immediate reversal ofMABP observed in pigs treated
with LPS but not receiving t-NAME, a delay (4 +_ 1
min) was observed in the onset of the beneficial
effect. MPAP declined after indomethacin treatment;
CO was transiently elevated and then decreased to
the same levels as in the untreated LPS-infused sur-
vivors (Fig. 1B and 2B).
In Group V, four animals pretreated with t-NAME
(3 mg/kg) prior to LPS infusion, tended to die at or
close to 30 rain after the start of the LPS infusion.
Indomethacin, given 5 min before the expected
death, reversed the serious hypotension in three of
four animals and prevented death. However, the
delay between the indomethacin injection and the
recovery of blood pressure was longer than in LPS-
treated and/or t-NAME post-LPS treated groups (8 _+
0.6 min vs 1 + 0.01 min and 4 + 0.6 min, respectively).
Furthermore, this recovery developed more slowly
(in 13.5 + 0.7 min instead of 60 s), a time that char-
acterized the beneficial effect of indomethacin in
pigs treated with LPS only. MPAP decreased after
indomethacin treatment, whereas CO was transiently
elevated and then decreased to a similar level as
observed in the untreated LPS-infused survivors (Fig.
lC and 2C).
Discussion
The main findings in the present study are: (1) LPS
infusion into the superior mesenteric artery resulted
in an almost even distribution of the experimental
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FIG. 2. Effect of i.v. treatment with indomethacin on arterial blood pressure (ABP) in anaesthetized pigs during endotoxin shock. Panel A, animals
untreated with L-NAME (Group III); Panel B, following and 3 mg/kg L-NAME given 5 and 10 min prior to indomethacin treatment (Group IV); and Panel
C, after L-NAME pretreatment 5 min prior to the start of LPS infusion (Group V; time-point not shown). Arrows indicate the time of administration of
either L-NAME or indomethacin, as appropriate. Time scale shows the time after the start of endotoxin infusion.
animals in two groups, non-survivors and survivors;
(2) indomethacin administration, starting shortly be-
fore the presumed death, immediately reversed the
hypotension and prevented death; (3) different
doses of .-NAME, also given before the expected
death, failed to restore blood pressure and prevent
death; moreover, t-NAME delayed the onset of the
beneficial effect of indomethacin treatment; and (4)
.-NAME, administered 10 min prior to the LPS infu-
sion markedly exacerbated the deleterious conse-
quences of this infusion, resulting in a greater delay
in the beneficial effect of indomethacin on
haemodynamics than in animals not receiving
NAME or in animals where t-NAME was administered
after LPS treatment.
Continuous LPS infusion in pigs induced death in
approximately half the animals and a prolonged state
of shock was observed in the surviving animals (up
to 1 h after termination of LPS infusion). The animals
were treated with indomethacin at the time of the
peak of LPS-induced hypotensive effect which was
followed by death in untreated animals within 5-10
min. Indomethacin treatment was effective in pre-
venting the imminent death and an immediate re-
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versal of the hypotension was observed with a con-
comitant decrease in pulmonary artery pressure and
an increase in cardiac output. This dose of
indomethacin treatment effectively reduced the re-
lease of cyclooxygenase products suggesting that the
beneficial effects of indomethacin treatment are due,
at least in part, to the inhibition of prostanoid synthe-
sis. However, the effect of indomethacin on blood
pressure was rapid in onset, reaching a maximum
within 60 s, implying that the vasoconstriction may
be independent of the inhibition of cyclooxygenase
pathway, Moreover, in non-survivors when
indomethacin was effective, no changes were ob-
served in the prostanoid release. In a similar way,
indomethacin restored the circulation during
mesenteric ischaemia/reperfusion-induced shock in
dogs; vasoconstriction developed in 30 s while the
decrease in prostanoid concentration was observed
later. Although indirect vasoconstriction via sup-
pression of local prostacyclin generation in a particu-
lar vascular bed, associated with a slower change in
the circulatory 6-keto-PGFl, cannot be entirely ex-
cluded, this does not seem very likely because both
aspirin and ibuprofen, despite being potent cyclo-Indomethacin, NO and endotoxin shock
oxygenase inhibitors, are not capable of eliciting a
rapid vasoconstrictor response.
9,1 The protective ef-
fect of ibuprofen against endotoxin shock develops
with a delay of 45 min1 and the improvement in the
survival during endotoxin shock in dogs by aspirin
occurs without any attenuation of the
haemodynamic effects of LPS.
Since blood pressure also returned to normal val-
ues within 90 s after inhibition of NO synthesis
during endotoxin shock in dogs, it is reasonable to
assume some interrelationship between the effects of
indomethacin and NO. However, in the present ex-
periments t-NAME failed to reverse the hypotension
suggesting that the use of inhibitors of both NO
synthases (Cai+-dependent constitutive and Cai/-in
dependent inducible) is not beneficial for treatment
of shock in pigs. Similar effects following inhibition
ofNO synthases have been found in rabbits and rats
as well as humans with endotoxin or septic shock
indicating that inhibition of endogenous NO synthe-
sis may be counter-productive. 5,11,12
It may be argued that the inability of I.-NAME to
restore blood pressure in LPS-treated pigs is due to
the dose of t-NAME employed in this study. However
the highest dose (3 mg/kg) was effective in blocking
NO synthesis as indicated by the reduced plasma
NO2- levels (M6zes et al., unpublished observations).
Furthermore, higher doses of r-NAME induced pro-
found reductions in cardiac output limiting blood
pressure increases in pigs3 and failed to restore the
haemodynamic changes induced by LPS infusion
(M6zes et al., unpublished observations).
Our findings are in accord with other studies,
suggesting that some NO formation may be benefi-
cial in endotoxin shock. 1’14’15 Indeed, NO production
appears to be responsible for the maintenance of a
low vascular tone within the pulmonary circulation. 15
Therefore, it seems likely that the expected rise in
arterial blood pressure following blockade of NO
synthesis is counteracted by the coincident fall in
cardiac output due to pulmonary vasoconstriction in
pigs. 13 The rapid increase in mean pulmonary arterial
pressure and the consecutive decrease in cardiac
output following LPS infusion were enhanced by any
form of t-NAME treatment in the present experi-
ments. These findings suggest that the vasodilator
tone exerted by NO is important for maintaining lung
perfusion in endotoxin shock, which view is further
supported by the observation that the most pro-
nounced NO induction following LPS can be found
in the lung. 16 Interestingly, NO synthase activity in
the aorta preceded the enzyme activity in the lung.
16
However, a negative inotropic effect of t-NAME,
either directly on the myocardium or indirectly via
coronary artery vasoconstriction contributing to the
fall in cardiac output, cannot be excluded. 17,8 A
recent study demonstrates that cytokines, including
tumour necrosis factor (TNF), induce a negative
inotropic effect on the heart mediated by cardiac NO
production. 19 In addition, hypotension induced by
TNF administration in dogs has been shown to be
reversed by NO synthase inhibition2 suggesting that
the hypotension might be caused by an excessive
NO production. Furthermore, in our endotoxic shock
model, in non-survivors a marked increase was de-
tected in plasma concentrations of TNF and NO2-
(M6zes et al., unpublished observations), but not
platelet-activating factor or eicosanoids. As hypoten-
sion following administration of either TNF or LPS
occurred within 30 min, one may assume that NO
might be produced by the constitutive NO synthase
rather than the inducible isoform, since its induction
requires 60-180 min.6 Indeed, TNF has been re-
ported to induce NO release within 5 min in the
papillary muscle preparation. 19 These observations
argue against an effect requiring gene transcription.
Therefore, the negative inotropic effects of cytokines
appear to result from enhanced activity of a consti-
tutive NO synthase in myocardium. 19 Based on the
above mentioned, it may be argued that the
endotoxin-induced haemodynamic changes (hypo-
tension and reduction in cardiac output) as well as
early death in non-survivors were mediated in con-
cert by TNF and NO. However, one should keep in
mind that the constitutive NO synthase can produce
only limited amounts of NO.2 Thus, the observed
haemodynamic changes can be evoked only partially
by NO. Consequently, it seems that TNF may act
directly as well as indirectly on the cardiovascular
system in non-survivors.
Taking into account that NO seems to be respon-
sible for the maintenance of the pulmonary circula-
tion as well as the hypotension in endotoxin shock
and that blockade of both isoforms of NO synthase
may exacerbate the endotoxin shock due to the
pulmonary insufficiency, the challenge is to restore
blood pressure without suppression of the pulmo-
nary circulation. The release of NO in the early and
late phase of endotoxaemia is triggered by two
distinct mechanisms; by activation of the constitutive
and the inducible NO synthase isoforms, respec-
tively. 16 It seems that with the use of non-selective
NO synthase inhibitors, such as t-NAME and
monomethyl-t-arginine (t-NMMA), the problem re-
mains unsolved.4,1a2 Selective inhibition of the in-
ducible NO synthase has been advocated as a useful
tool in the late phase of endotoxin shock.
11 In con-
trast, the enhanced formation of NO by the constitu-
tive enzyme seems to account for the immediate
hypotension in response to LPS16 and a similar
mechanism has been observed in haemorrhagic
shock in anaesthetized rats. 22 Therefore, it is conceiv-
able that the constitutive NO synthase should be
blocked in the early phase of endotoxin shock. This
view is supported by the observation that in the early
phase of endotoxin shock the constitutive NO
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synthase is more abundantly present in the aorta than
in the lung.
16 Consequently, the use of an inhibitor
of the constitutive enzyme may reverse the hypoten-
sion without disrupting the pulmonary homeostasis.
In the present study, indomethacin reversed hypo-
tension, elevated cardiac output and prevented
death. This beneficial effect on blood pressure was
rapid in onset, reaching its maximum in 60 s, imply-
ing that vasoconstriction seen after indomethacin
may be due to the inhibition of a rapidly degrading
potent vasodilator like NO. However, the rapid re-
lease of a potent vasoconstrictor cannot be excluded.
Nevertheless, our results demonstrate a long delay in
the beneficial effect of indomethacin after the inhibi-
tion of NO synthesis; therefore, the release of a
vasoconstrictor does not seem very likely. Further-
more, the observed delay in the beneficial effect of
indomethacin seems to depend on the duration of
inhibition of both NO synthases. Recently, we ob-
served a significant reduction in plasma nitrite con-
centration following L-NAME (3 mg/kg) from 15 min
to 120 min in pigs (M6zes et al., unpublished obser-
vations). Since NO synthesis inhibition is more pro-
nounced after 15 min, it is conceivable that in L-
NAME pretreated animals the reversal of the hypo-
tension takes longer (20-25 min after L-NAME) than
in L-NAME post-LPS treated animals (3-8 min after L-
NAME) or in the absence of L-NAME in LPS-treated
animals. However, it is to be noted that the experi-
ments were performed in pentobarbitone anaesthe-
tized animals and it has been shown that this type of
anaesthesia may delay the onset of pressor responses
tO L-NAME. 23 Hence it may be suggested that anaes-
thesia contributed in part to the more pronounced
delay observed in L-NAME pretreated animals.
Apart from its cyclooxygenase inhibitory action
indomethacin possesses other activities such as
blocking calcium influx. 23"24 One possible explana-
tion for the rapid restoration of blood pressure fol-
lowing indomethacin administration may be a selec-
tive inhibition of NO synthase. Since indomethacin
inhibits Ca
2+ uptake,24 the activity of the calcium-
dependent NO synthase may be reduced. This view
is supported by the observation that NO release is
reduced by indomethacin-isolated rabbit hearts fol-
lowing reperfusion25 and that nifedipine, a calcium
channel antagonist, inhibits the induction of NO
synthase by LPS. 26 These observations suggest that
the rapid beneficial effect of indomethacin on
haemodynamics in endotoxic shock may be medi-
ated by some reduction in NO production or release.
However, one should keep in mind that indo-
methacin demonstrated its beneficial effect on the
circulation after a certain delay following L-NAME
treatment suggesting that NO is not the only factor
determining the blood pressure during endotoxic
shock.
Finally, by increasing the intracellular cAMP level,
24
indomethacin may alter the balance between cAMP
and cGMP. Because of their opposing effects on the
circulation and platelet aggregation,
27 the balance
between cAMP and cGMP might be more important
than the change in their respective levels. Since NO
is known to elevate cGMP levels, this explanation
also suggests some interference between indome-
thacin and NO.
In summary, regardless of the precise mechanism,
indomethacin administration during the early phase
of LPS-induced shock reversed hypotension, de-
creased pulmonary pressure and improved cardiac
output. It should be noted that the effect of
indomethacin on haemodynamics preceded the ef-
fective blockade of cyclooxygenase enzyme. Indo-
methacin was less effective after the inhibition of
both NO synthases suggesting that the beneficial
effect of indomethacin in endotoxin shock might be
partly related to either selective inhibition of the
(Cai+-dependent) NO synthase, to antagonism of NO
itself or both. However, the observation that the
beneficial effect of indomethacin was delayed after
NO synthase inhibition and was less effective sug-
gests that NO is not the only factor determining the
hypotension during endotoxic shock.
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